» Articles » PMID: 9684805

Peripheral Blood Platelets Express VEGF-C and VEGF Which Are Released During Platelet Activation

Overview
Journal Thromb Haemost
Publisher Thieme
Date 1998 Jul 31
PMID 9684805
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

VEGF-C is a recently characterised endothelial growth factor structurally related to vascular endothelial growth factor (VEGF). We studied the expression of VEGF-C and VEGF in the cells of peripheral blood and in the umbilical cord blood CD 34+ cells, representing haematopoietic progenitor cells. Expression of VEGF-C was detected in the CD34+ cells. In peripheral blood VEGF-C mRNA was restricted to platelets and T-cells. In contrast to the expression pattern of VEGF-C, VEGF mRNA was detected in all peripheral blood cell fractions studied, and also in CD34+ cells. VEGF-C mRNA was also detected in fresh bone marrow samples of acute leukaemia patients, but the expression did not show lineage specificity. VEGF-C and VEGF polypeptides were present in platelets and they were released from activated platelets together with the release of beta-thromboglobulin, suggesting that VEGF-C and VEGF reside in the alpha-granules of platelets. VEGF-C and VEGF, released from activated platelets, may have a role in angiogenesis during wound healing, and possibly also in other pathological conditions, such as atherosclerosis, tumour growth, and metastasis formation.

Citing Articles

Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.

Hirakawa T, Yamaguchi K, Funaishi K, Shimoji K, Sakamoto S, Horimasu Y Cancers (Basel). 2025; 17(4).

PMID: 40002167 PMC: 11853576. DOI: 10.3390/cancers17040572.


Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function.

Vachon L, Jean G, Milasan A, Babran S, Lacroix E, Guadarrama Bello D Commun Biol. 2024; 7(1):975.

PMID: 39128945 PMC: 11317532. DOI: 10.1038/s42003-024-06675-8.


Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.

Faria P, Resende R, Cardoso A Purinergic Signal. 2024; 20(6):607-616.

PMID: 38753131 PMC: 11554953. DOI: 10.1007/s11302-024-10020-3.


Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.

Li D, Guo J, Song Q, Hu X, Bao X, Lu J Transl Cancer Res. 2022; 11(11):4037-4050.

PMID: 36523315 PMC: 9745370. DOI: 10.21037/tcr-22-1197.


Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels.

Sundblom J, Skare T, Holm O, Welin S, Braun M, Nilsson P PLoS One. 2022; 17(11):e0278166.

PMID: 36441756 PMC: 9704563. DOI: 10.1371/journal.pone.0278166.